Press to navigate, Enter to select, Esc to close
Recent Searches
Trending Now

PSK (Krestin)

supplement Verified

Specifically for Colorectal Cancer

0% effective
0 votes
0 up0 down

Why it works for Colorectal Cancer:

Immune activation (TLR2-mediated): PSK is a selective Toll-like receptor-2 (TLR2) agonist that matures dendritic cells and boosts CD8⁺ T-cell and NK-cell activity—mechanisms that can enhance anti-tumour immunity during/after chemo-radiation. AACR Journals

Counters treatment-related immunosuppression & may reduce metastasis: Reviews describe PSK restoring immune balance (e.g., offsetting TGF-β–related suppression) and directly aiding anti-metastatic effects, which is consistent with clinical signals in CRC. SpringerLink

Regulatory/clinical reality: PSK has been a prescription adjuvant in Japan since the 1970s (not approved in the US/Australia), used with surgery and chemotherapy rather than as a stand-alone cancer drug. AACR Journals

Safety background: Large clinical use in Japan reports few adverse events; see warnings below. Cancer.gov

How to use for Colorectal Cancer:

Dose most often used: 3 g/day orally, typically 1 g three times daily as an adjuvant after curative surgery and with chemotherapy. Duration in trials ranged from months to multiple years. Nature

Example CRC regimen (randomised trial): After mitomycin C, patients received PSK 3 g/day + UFT (tegafur/uracil 300 mg/day) vs UFT alone for 2 years. Nature

Typical clinical context: Used with fluoropyrimidines (e.g., UFT/5-FU) as postoperative adjuvant therapy in stage II–III disease. Nature

General dosing notes compiled for clinicians: Natural-products monographs summarise PSK dosing as 3 g/day orally, sometimes for up to 7 years in post-surgical colon/CRC/gastric cancer patients (always adjunctive). Drugs.com

Scientific Evidence for Colorectal Cancer:

Meta-analysis of 3 centrally randomised CRC trials (n=1,094): Adding PSK to standard adjuvant chemotherapy improved overall survival (risk ratio 0.71, 95% CI 0.55–0.90) and disease-free survival (risk ratio 0.72, 95% CI 0.58–0.90) after curative resection. SpringerLink

Randomised controlled trial (BJC 2004; stage II–III): PSK 3 g/day + UFT vs UFT alone for 2 years: higher 5-year DFS (73.0% vs 58.8%; p=0.016), with especially notable gains in stage III patients; adverse effects were mild. Nature

Earlier RCT (Diseases of the Colon & Rectum 1992): Adjuvant PSK after curative CRC surgery showed longer disease-free intervals vs control. (Abstract and citation available.) Lippincott Journals

Evidence summaries (NCI PDQ for professionals): Lists PSK as a Japanese-approved adjuvant from T. versicolor with few adverse events and cites multiple CRC trials/meta-analyses; also notes mechanistic and rectal-cancer chemoradiation research. Cancer.gov

Network/meta-analyses across GI cancers: Broader syntheses suggest PSK can confer benefit as an add-on to chemotherapy in gastrointestinal cancers (heterogeneous by site/regimen). oncotarget.com

Specific Warnings for Colorectal Cancer:

Do not self-substitute for guideline therapy: PSK has only been studied as an adjunct; skipping standard chemo-/radiotherapy risks undertreatment. (See NCI overview of medicinal mushrooms as adjuncts.) Cancer.gov

Regulatory status (Australia): PSK is not TGA-approved as a medicine in Australia; any use should go through an oncologist (e.g., clinical trial or special access pathways). Therapeutic Goods Administration (TGA)

Adverse effects reported: Usually mild (e.g., diarrhoea, darkened stools, occasional nail pigmentation). Drugs.com

Pregnancy/lactation: Avoid—insufficient safety data. Drugs.com

Drug interactions: None well documented in monographs, but because PSK is immunostimulatory, use caution with immunosuppressants, autoimmune conditions, or post-transplant situations; coordinate with the treating team. Drugs.com

Product quality: Outside Japan, “turkey tail” supplements vary in content and aren’t equivalent to prescription-grade PSK; quality inconsistency is a known issue with supplements. Cancer.gov

General Information (All Ailments)

Note: You are viewing ailment-specific information above. This section shows the general remedy information for all conditions.

What It Is

PSK (Polysaccharide Krestin), also known simply as Krestin, is a protein-bound polysaccharide derived from the Coriolus versicolor mushroom (also called Trametes versicolor or “Turkey Tail”). It is a biologically active compound composed primarily of β-glucans linked with peptides. PSK has been widely used in Japan and other Asian countries as an immunotherapeutic agent, particularly as an adjuvant treatment for cancer. It is classified as a biological response modifier (BRM), meaning it modulates the body’s immune system to enhance its ability to fight disease.

How It Works

PSK works through immune modulation, meaning it helps stimulate or regulate the body’s natural immune defenses. The key mechanisms include:

  1. Activation of Immune Cells: PSK activates various immune cells such as macrophages, dendritic cells, natural killer (NK) cells, and T lymphocytes. This activation enhances the body’s ability to identify and destroy abnormal or cancerous cells.
  2. Cytokine Regulation: It promotes the production of cytokines (e.g., interleukins, interferons, and tumor necrosis factors), which are signaling molecules that coordinate the immune response and help orchestrate anti-tumor activity.
  3. Enhancement of Antitumor Immunity: PSK is believed to increase the presentation of tumor antigens to the immune system, improving immune surveillance and the targeting of tumor cells.
  4. Reduction of Immunosuppression from Chemotherapy: Many conventional cancer treatments (like chemotherapy and radiation) suppress immune function. PSK helps counteract immunosuppression, allowing the body to recover immune competency during or after therapy.
  5. Antioxidant and Anti-inflammatory Effects: Beyond immune modulation, PSK exhibits antioxidant properties that protect cells from oxidative damage and may help regulate inflammatory responses that contribute to disease progression.

Why It’s Important

PSK’s importance lies in its role as a complementary cancer therapy and immune-enhancing agent. Key points include:

  • Clinical Use in Oncology: PSK has been approved for clinical use in Japan since the 1970s as an adjunct therapy for cancers such as gastric, colorectal, lung, breast, and esophageal cancers. It is used alongside chemotherapy to improve survival rates and quality of life.
  • Evidence of Improved Outcomes: Studies (mainly from Japan and China) have reported that patients receiving PSK in combination with conventional cancer therapies often experience longer survival times and lower recurrence rates compared to those receiving standard therapy alone.
  • Support for Immune Health: Beyond oncology, PSK’s immune-boosting effects have led to its investigation for viral infections, chronic fatigue, and general immune support, though evidence outside cancer remains limited.
  • Natural Source: Derived from a medicinal mushroom with a long history of use in traditional Asian medicine, PSK represents a bridge between modern pharmacology and natural immunotherapy.

Considerations

While PSK shows promise and has clinical backing in certain countries, there are important considerations to keep in mind:

  1. Regulatory Differences: PSK is an approved prescription drug in Japan, but in most Western countries (including the U.S.), it is classified as a dietary supplement or investigational substance, not an approved pharmaceutical agent.
  2. Scientific Debate and Evidence Quality: Although numerous studies (especially in Asia) support PSK’s efficacy, methodological differences and variations in study quality have made it difficult for regulatory bodies like the FDA or EMA to fully endorse it as a standard therapy.
  3. Dosage and Administration: In clinical settings, PSK is typically administered orally in standardized doses as part of a structured cancer treatment plan. Over-the-counter versions may differ in purity and potency.
  4. Potential Side Effects: PSK is generally well tolerated, but some individuals may experience digestive upset, darkened stool, nausea, or allergic reactions. Because it modulates immune function, caution is advised in people with autoimmune diseases or those on immunosuppressive medications.
  5. Interactions with Conventional Therapies: Patients should consult healthcare providers before combining PSK with other treatments, as immune-boosting agents could theoretically interfere with immunosuppressive or cytotoxic drugs.
  6. Product Quality Variability: Since PSK supplements sold outside Japan are not strictly regulated, product quality, extraction methods, and concentration can vary widely, affecting safety and efficacy.

Helps with these conditions

PSK (Krestin) is most effective for general wellness support with emerging research . The effectiveness varies by condition based on clinical evidence and user experiences.

Colorectal Cancer 0% effective
1
Conditions
0
Total Votes
5
Studies
0%
Avg. Effectiveness

Detailed Information by Condition

Colorectal Cancer

0% effective

Immune activation (TLR2-mediated): PSK is a selective Toll-like receptor-2 (TLR2) agonist that matures dendritic cells and boosts CD8⁺ T-cell and NK-c...

0 votes Updated 1 month ago 5 studies cited

Community Discussion

Share results, tips, and questions about PSK (Krestin).

0 comments 0 participants
Only registered members can join the discussion.
Please log in or create an account to share your thoughts.

Loading discussion...

No comments yet. Be the first to start the conversation!

Discussion for Colorectal Cancer

Talk specifically about using PSK (Krestin) for Colorectal Cancer.

0 comments 0 participants
Only registered members can join the discussion.
Please log in or create an account to share your thoughts.

Loading discussion...

No comments yet. Be the first to start the conversation!

Remedy Statistics

Effectiveness
Not yet rated
Safety Rating 5/10

Helps With These Conditions

Recommended Products

No recommended products added yet.

Submitted By

Admin User
1322 reputation